Search results
Results from the WOW.Com Content Network
The questions on the WOMAC are a subset of the questions of the Hip disability and osteoarthritis outcome score (HOOS). [4] Thus, a HOOS survey may also be used to determine a WOMAC score. A WOMAC test takes about 12 minutes, but is also available in a short form, (although this has not been as extensively tested as the full version).
This quantitative version is known by several names: Quantitative Sørensen–Dice index [4] Quantitative Sørensen index [4] Quantitative Dice index [4] Bray–Curtis similarity (1 minus the Bray-Curtis dissimilarity) [4] Czekanowski's quantitative index [4] Steinhaus index [4] Pielou's percentage similarity [4] 1 minus the Hellinger distance [18]
Osteoarthritis and Cartilage is monthly peer-reviewed medical journal covering research in orthopedics and rheumatology. It is an official journal of the Osteoarthritis Research Society International , published on their behalf by Elsevier .
Osteoarthritis is the most common form of arthritis, affecting about 237 million people or 3.3% of the world's population as of 2015. [4] [12] It becomes more common as people age. [1] Among those over 60 years old, about 10% of males and 18% of females are affected. [2] Osteoarthritis is the cause of about 2% of years lived with disability. [12]
Vaishya was the Chairman of IT, e-library and Web resource Committee, and Basic Science and Research committee of Indian Orthopaedic Association. He performed the first pre plan PSI total knee arthroplasty, in Northern India in May 2013. He was the only person from the Indian subcontinent to be invited as a faculty member for the UK Cartilage ...
[1] [2] The journal was established in 1999 as Arthritis Research, obtaining its current title in. [3] The journal's print version ceased in 2010 with volume 12, number 6, and the journal converted to an online only format. [2] According to the Journal Citation Reports, the journal has a 2017 impact factor of 4.269. [4]
The Osteoarthritis Research Society International advises arthritis sufferers to discontinue glucosamine therapy if they notice no benefit within six months [12] and the National Institute for Clinical Excellence no longer recommends its use. [13] Despite the difficulty in determining the efficacy of glucosamine, it remains a viable treatment ...
The RAQoL was developed by Galen Research, the University of Leeds and the Academic Hospital Maastricht, and was first published in 1997. [5] It was the first patient completed quality of life questionnaire that focused on rheumatoid arthritis [6] and is distinct from other questionnaires as it includes physical contact as a dimension of quality of life. [3]